Carvacrol stimulated the increase of intracellular Ca2+concentration, but was inactive in stimulating Ca2+ by TRPV3 siRNA in breast cancer cells, demonstrating the opposite effect of Carvacrol and TRPV3 siRNA in BC progression (migration, proliferation and apoptosis). This evidence concerns the gene TRPV3 and breast carcinoma.